A haplotype relative risk study of the dopamine D4 receptor (DRD4) exon III repeat polymorphism and attention deficit hyperactivity disorder (ADHD)

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 96, Issue 3, 2000, Pages 258-261

  Eisenberg, Jacques ^a   Zohar, Ada ^b   Mei Tal, Galit ^a   Steinberg, Avraham ^c   Tartakovsky, Eduardo ^a   Gritsenko, Inga ^a   Nemanov, Lubov ^a   Ebstein, Richard P ^a  

^a HERZOG HOSPITAL   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Association; Attention deficit hyperactivity disorder (ADHD); Complex genetic disease; Dopamine D4 receptor exon III; Haplotype relative risk; Impulsive; Polymorphism

Indexed keywords

DOPAMINE 4 RECEPTOR;

ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; EXON; FAMILY STUDY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; IMPULSIVENESS; PRIORITY JOURNAL;

ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHILD; EXONS; HAPLOTYPES; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; RISK; RISK FACTORS; TANDEM REPEAT SEQUENCES;

EID: 0034640706     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/1096-8628(20000612)96:3<258::AID-AJMG4>3.0.CO;2-8     Document Type: Article

References (28)

1. Allison DB. 1997. Transmission-disequilibrium tests for quantitative traits [published erratum appears in Am J Hum Genet 1997 Jun;60(6): 1571], Am J Hum Genet 60:676-690.
2. Benjamin J, Li L, Patterson C, Greenberg BD, Murphy DL, Hamer DH. 1996. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nat Genet 12:81-84.
3. Biederman J. 1998. Attention-deficit/hyperactivity disorder: a life-span perspective. J Clin Psychiatry 59(Suppl 7):4-16.
4. Biederman J, Wilens T, Mick E, Faraone SV, Weber W, Curtis S, Thornell A, Pfister K, Jetton JG, Soriano J. 1997. Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 36:21-29.
5. Castellanos FX. 1997. Toward a pathophysiology of attention-deficit/ hyperactivity disorder. Clin Pediatr 36:381-393.
6. Castellanos FX, Lau E, Tayebi N, Lee P, Long RE, Giedd JN, Sharp W, Marsh WL, Walter JM, Hamburger SD, Ginns EI, Rapoport JL, Sidransky E. 1998. Lack of an association between a dopamine-4 receptor polymorphism and attention-deficit/hyperactivity disorder: genetic and brain morphometric analyses. Mol Psychiatry 3:431-434.
7. Comings DE, Wu S, Chiu C, Ring RH, Gade R, Ahn C, MacMurray JP, Dietz G, Muhleman D. 1996. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes - DRD2, D beta H, and DAT1. Am J Med Genet 67:264-288.
8. Conners CK. 1998. Rating scales in attention-deficit/hyperactivity disorder: use in assessment and treatment monitoring. J Clin Psychiatry 59(Suppl 7):24-30.
9. Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL. 1995. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56:993-998.
10. Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, Bennett ER, Nemanov L, Katz M, Belmaker RH. 1996. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nat Genet 12:78-80.
11. Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky A, Gritsenko I, Nemanov L, Ebstein RP. in press. A haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity val allele with ADHD impulsive-hyperactive phenotype. Am J Med Genet (Neuropsychiatr Genet).
12. Ewens WJ, Spielman RS. 1995. The transmission/disequilibrium test: history, subdivision, and admixture. Am J Hum Genet 57:455-464.
13. Falk CT, Rubenstein P. 1987. Haplotype relative risk: an easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 51:227-233.
14. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. 1997. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 2:311-313.
15. Johnson DE, Waid LR, Anton RF. 1997. Childhood hyperactivity, gender, and Cloninger's personality dimensions in alcoholics. Addict Behav 22: 649-653.
16. Kotler M, Cohen H, Segman R, Gritsenko I, Nemanov L, Lerer B, Kramer I, Zer-Zion M, Kletz I, Ebstein RP. 1997. Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects. Mol Psychiatry 2:251-254.
17. LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N, Kennedy JL. 1996. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder [see comments]. Mol Psychiatry 1:121-124.
18. Mel H, Horowitz R, Ohel N, Kramer I, Kotler M, Cohen H, Gritsenko I, Ebstein RP. 1998. Additional evidence for an association between the dopamine D4 receptor (D4DR) exon III seven-repeat allele and substance abuse in opioid dependent subjects: relationship of treatment retention to genotype and personality. Addiction Biology 3:473-481.
19. Milberger S, Biederman J, Faraone SV, Chen L, Jones, J. 1997. Further evidence of an association between attention-deficit/hyperactivity disorder and cigarette smoking. Findings from a high-risk sample of siblings. Am J Addict 6:205-217.
20. Rowe DC, Stever C, Giedinghagen LN, Gard JM, Cleveland HH, Terris ST, Mohr JH, Sherman S, Abramowitz A, Waldman ID. 1998. Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder. Mol Psychiatry 3:419-426.
21. Smalley SL, Bailey JN, Palmer CG, Cantwell DP, McGough JJ, Del'Homme MA, Asarnow JR, Woodward JA, Ramsey C, Nelson SF. 1998. Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder. Mol Psychiatry 3:427-430.
22. Solanto MV. 1998. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 94:127-152.
23. Spielman RS, McGinnis RE, Ewans WJ. 1993. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516.
24. Sunohara GA, Swanson JM, LaHoste G, Wigal S, King N. Sam F. 1996. Association of dopamine receptor genes in attention deficit hyperactivity disorder. Am J Med Genet 59S:A1370.
25. Swanson J, Castellanos FX, Murias M, LaHoste G, Kennedy J. 1998a. Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder. Curr Opin Neurobiol 8:263-271.
26. Swanson JM, Sunohara GA, Kennedy JL, Regino R, Fineberg E, Wigal T, Lerner M, Williams L, LaHoste GJ, Wigal S. 1998b. Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol Psychiatry 3:38-41.
27. Thapar A. 1998. Attention deficit hyperactivity disorder: unravelling the molecular genetics. Mol Psychiatry 3:370-372.
28. Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL, Cleveland HH, Sanders ML, Gard JM, Stever C. 1998. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet 63:1767-1776.